Patents/Licenses

Granted (2)

  • US Patent US10159735B2, 2013 “Photocleavable drug conjugates.” Friedman SH, Jain PK, Karunakaran D and Sarode B. Granted 2018.
  • US Patent App. 16/099,147, 2017 “Methods and uses for remotely triggered protease activity measurements.” Bhatia SN, Kwong GA, Jain PK, Dudani JS and Schurle S. (16/099,147, CA3022928A1, WO2017193070A1, EP3452407A4) Granted 2020

Pending (5)

  • US Patent App. 62/489,163, 2018 “Drug Conjugates with Photocleavable Solubility Modulators.” Friedman SH, Nandela K, Sarode B, Jain P, Karunakaran D, Chintala S and Shah P. (WO2018200462A1).
  • U.S. Patent App. 62/932,823, 2019 Jain PK and Nguyen LT.
  • U.S. Patent App. 62/934,217, 2019 Jain PK, Downing M, Nguyen LT and Pawlyshyn B.
  • U.S. Patent App. 62/952,762, 2019 Jain PK, Nguyen LT and Smith B.
  • U.S. Patent App. 62/975,010, 2020 Jain PK, Downing M.

Licensed (1)

  • US Patent App. 16/099,147, 2017 “Methods and uses for remotely triggered protease activity measurements.” Bhatia SN, Kwong GA, Jain PK, Dudani JS and Schurle S. (16/099,147, CA3022928A1, WO2017193070A1, EP3452407A4) Licensed 2018